COMP <GO>
AMPH vs VSTM // EV/EBITDA & P/E VALUATION
Amphastar Pharmaceuticals Inc. (NASDAQ) VS. Verastem Inc. (NASDAQ) • 15-METRIC TALLY: AMPH 7
— VSTM 2
■ METRIC PARITY
LAST: $26.93 (+2.28%) • MKT CAP: $1.15B
valuation
9.4x
LAST: $9.66 (-1.78%) • MKT CAP: $1.17B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMPH VS. VSTM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMPH | VSTM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 49.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.00% | -35.00% | +44.00 | AMPH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 9.4x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 10.58% | -11.72% | +22.30 | AMPH | /fcf-yield <GO> |
| Operating Margin | 19.50% | -60.00% | +79.50 | AMPH | /operating-margins <GO> |
| Net Profit Margin | 13.60% | -60.00% | +73.60 | AMPH | /net-margins <GO> |
| Revenue Growth (YoY) | -1.70% | 180.00% | -181.70 | VSTM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.47 | 0.20 | +2.27 | AMPH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 3/9 | +4.00 | AMPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.8 | 61.7 | +5.17 | AMPH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.15B | $1.17B | -$27.4M | VSTM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMPH REV | VSTM REV | AMPH GROSS % | VSTM GROSS % | AMPH FCF | VSTM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $719.9M | $30.9M | 49.5% | — | $121.2M | -$137.5M |
| FY 2024 | $732.0M | $10.0M | 51.1% | — | $172.3M | -$104.8M |
| FY 2023 | $644.4M | $0 | — | — | $183.5M | -$86.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMPH // BETA —
VSTM // BETA —